HEADER OXIDOREDUCTASE 10-NOV-08 2W3A TITLE HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND TRIMETHOPRIM COMPND MOL_ID: 1; COMPND 2 MOLECULE: DIHYDROFOLATE REDUCTASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 1.5.1.3; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PET11A; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PDFR KEYWDS NONCLASSICAL ANTIFOLATES, ONE-CARBON METABOLISM, LIPOPHILIC KEYWDS 2 ANTIFOLATES, NADP, REDUCTASE, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR A.K.W.LEUNG,R.C.REYNOLDS,D.W.BORHANI REVDAT 4 01-MAY-24 2W3A 1 REMARK REVDAT 3 08-MAY-19 2W3A 1 REMARK REVDAT 2 06-MAR-19 2W3A 1 REMARK REVDAT 1 17-NOV-09 2W3A 0 JRNL AUTH A.K.W.LEUNG,L.J.ROSS,S.ZYWNO-VAN GINKEL,R.C.REYNOLDS, JRNL AUTH 2 L.E.SEITZ,V.PATHAK,W.W.BARROW,E.L.WHITE,W.J.SULING, JRNL AUTH 3 J.R.PIPER,D.W.BORHANI JRNL TITL STRUCTURAL BASIS FOR SELECTIVE INHIBITION OF MYCOBACTERIUM JRNL TITL 2 AVIUM DIHYDROFOLATE REDUCTASE BY A LIPOPHILIC ANTIFOLATE JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 9.90 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 85.4 REMARK 3 NUMBER OF REFLECTIONS : 52301 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.181 REMARK 3 R VALUE (WORKING SET) : 0.179 REMARK 3 FREE R VALUE : 0.214 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2810 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.54 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1258 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.1570 REMARK 3 BIN FREE R VALUE SET COUNT : 67 REMARK 3 BIN FREE R VALUE : 0.2030 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2957 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 155 REMARK 3 SOLVENT ATOMS : 408 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 16.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 16.75 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.19000 REMARK 3 B22 (A**2) : 0.09000 REMARK 3 B33 (A**2) : -0.28000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.125 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.091 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.049 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.788 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.945 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.931 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3338 ; 0.012 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 2308 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4554 ; 1.506 ; 2.027 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5641 ; 1.198 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 403 ; 5.766 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 136 ;37.780 ;24.853 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 575 ;11.995 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 13 ;13.104 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 479 ; 0.087 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3655 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 642 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 528 ; 0.200 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 2219 ; 0.192 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1533 ; 0.175 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 1631 ; 0.081 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 200 ; 0.150 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 6 ; 0.089 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 49 ; 0.166 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 54 ; 0.150 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2560 ; 1.377 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3201 ; 1.633 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1652 ; 2.433 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1353 ; 3.129 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 3 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 1 A 186 REMARK 3 RESIDUE RANGE : A 1188 A 1188 REMARK 3 RESIDUE RANGE : A 1190 A 1190 REMARK 3 ORIGIN FOR THE GROUP (A): 0.5910 23.4590 -1.4220 REMARK 3 T TENSOR REMARK 3 T11: -0.0350 T22: -0.0344 REMARK 3 T33: -0.0129 T12: -0.0509 REMARK 3 T13: -0.0254 T23: -0.0052 REMARK 3 L TENSOR REMARK 3 L11: 1.3892 L22: 1.3486 REMARK 3 L33: 0.9913 L12: 0.3335 REMARK 3 L13: -0.0630 L23: 0.1033 REMARK 3 S TENSOR REMARK 3 S11: 0.0692 S12: -0.1220 S13: -0.0183 REMARK 3 S21: 0.2153 S22: -0.0761 S23: -0.0723 REMARK 3 S31: 0.0672 S32: -0.0324 S33: 0.0069 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 3 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 1 B 186 REMARK 3 RESIDUE RANGE : B 1188 B 1188 REMARK 3 RESIDUE RANGE : B 1189 B 1189 REMARK 3 ORIGIN FOR THE GROUP (A): 21.3840 45.4820 22.7150 REMARK 3 T TENSOR REMARK 3 T11: -0.0487 T22: -0.0282 REMARK 3 T33: -0.0197 T12: 0.0396 REMARK 3 T13: 0.0117 T23: -0.0010 REMARK 3 L TENSOR REMARK 3 L11: 0.9958 L22: 1.2016 REMARK 3 L33: 1.3864 L12: -0.2134 REMARK 3 L13: -0.4969 L23: 0.4862 REMARK 3 S TENSOR REMARK 3 S11: -0.0745 S12: -0.1410 S13: 0.0331 REMARK 3 S21: 0.0799 S22: 0.0090 S23: 0.0026 REMARK 3 S31: 0.0973 S32: 0.0789 S33: 0.0655 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 2W3A COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 10-NOV-08. REMARK 100 THE DEPOSITION ID IS D_1290038064. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-JUL-97 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.75 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CHESS REMARK 200 BEAMLINE : A1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.908 REMARK 200 MONOCHROMATOR : SI REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM-1 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 55140 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -10.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 85.7 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.05000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.54 REMARK 200 COMPLETENESS FOR SHELL (%) : 28.3 REMARK 200 DATA REDUNDANCY IN SHELL : 1.10 REMARK 200 R MERGE FOR SHELL (I) : 0.19000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: UNPUBLISHED HUMAN DHFR FOLATE COMPLEX REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.47 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.34 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: HUMAN DHFR/FOLATE COMPLEX WAS MIXED REMARK 280 WITH NADPH AND TRIMETHOPRIM (BOTH 2 MM FINAL). CRYSTALS WERE REMARK 280 GROWN BY HANGING DROP VAPOR DIFFUSION AT 277 K BY MIXING EQUAL REMARK 280 VOLUMES OF PROTEIN/NADPH/TMP WITH RESERVOIR (24% PEG 4000, 200 REMARK 280 MM LI2SO4, 100 MM TRIS.HCL, PH 8.75). TRUNCATED TRIANGULAR REMARK 280 CRYSTALS APPEARED SLOWLY, IN ABOUT A MONTH. THE CRYSTAL WAS REMARK 280 CRYOPROTECTED WITH 15% GLYCEROL AND FLASH-COOLED IN LIQUID N2., REMARK 280 VAPOR DIFFUSION, HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 48.28800 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 48.28800 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 44.23400 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 47.00700 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 44.23400 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 47.00700 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 48.28800 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 44.23400 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 47.00700 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 48.28800 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 44.23400 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 47.00700 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 0 REMARK 465 MET B 0 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 32 NE CZ NH1 NH2 REMARK 470 LYS A 68 CE NZ REMARK 470 LYS A 80 CG CD CE NZ REMARK 470 ARG A 91 CD NE CZ NH1 NH2 REMARK 470 ASP A 141 CG OD1 OD2 REMARK 470 GLU A 143 CD OE1 OE2 REMARK 470 GLU A 150 CG CD OE1 OE2 REMARK 470 ARG B 28 NE CZ NH1 NH2 REMARK 470 GLN B 84 CD OE1 NE2 REMARK 470 LYS B 98 CG CD CE NZ REMARK 470 GLU B 101 CG CD OE1 OE2 REMARK 470 GLU B 150 CG CD OE1 OE2 REMARK 470 GLU B 161 CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 2071 O HOH A 2148 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 110 -95.26 -94.49 REMARK 500 MET A 139 50.75 -90.48 REMARK 500 ASN B 107 18.11 59.62 REMARK 500 ASP B 110 -94.53 -102.22 REMARK 500 MET B 139 43.48 -86.57 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2027 DISTANCE = 6.33 ANGSTROMS REMARK 525 HOH A2033 DISTANCE = 6.72 ANGSTROMS REMARK 525 HOH B2009 DISTANCE = 6.58 ANGSTROMS REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 GLYCEROL (GOL): 1,2,3-PROPANETRIOL REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1187 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NDP A 1188 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1189 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TOP A 1190 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 1187 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NDP B 1188 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TOP B 1189 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2C2S RELATED DB: PDB REMARK 900 HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 2,4-DIAMINO- REMARK 900 5-(1-O- CARBORANYLMETHYL)-6-METHYLPYRIMIDINE, A NOVEL BORON REMARK 900 CONTANING, NONCLASSICAL ANTIFOLATE REMARK 900 RELATED ID: 2W3M RELATED DB: PDB REMARK 900 HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND FOLATE REMARK 900 RELATED ID: 1DHF RELATED DB: PDB REMARK 900 DIHYDROFOLATE REDUCTASE (DHFR) COMPLEX WITH FOLATE REMARK 900 RELATED ID: 2DHF RELATED DB: PDB REMARK 900 DIHYDROFOLATE REDUCTASE (DHFR) COMPLEX WITH 5 -DEAZAFOLATE REMARK 900 RELATED ID: 1S3W RELATED DB: PDB REMARK 900 STRUCTURE DETERMINATION OF TETRAHYDROQUINAZOLINEANTIFOALTES IN REMARK 900 COMPLEX WITH HUMAN AND PNEUMOCYSTIS CARINIIDIHYDROFOLATE REDUCTASE: REMARK 900 CORRELATIONS OF ENZYMESELECTIVITY AND STEREOCHEMISTRY REMARK 900 RELATED ID: 2W3B RELATED DB: PDB REMARK 900 HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND A LIPOPHILIC REMARK 900 ANTIFOLATE SELECTIVE FOR MYCOBACTERIUM AVIUM DHFR, 6-((2,5- REMARK 900 DIETHOXYPHENYL)AMINOMETHYL)-2,4-DIAMINO-5- METHYLPYRIDO(2,3-D) REMARK 900 PYRIMIDINE (SRI-8686) REMARK 900 RELATED ID: 1S3V RELATED DB: PDB REMARK 900 STRUCTURE DETERMINATION OF TETRAHYDROQUINAZOLINEANTIFOLATES IN REMARK 900 COMPLEX WITH HUMAN AND PNEUMOCYSTIS CARINIIDIHYDROFOLATE REDUCTASE: REMARK 900 CORRELATIONS OF ENZYMESELECTIVITY AND STEREOCHEMISTRY REMARK 900 RELATED ID: 1PD8 RELATED DB: PDB REMARK 900 ANALYSIS OF THREE CRYSTAL STRUCTURE DETERMINATIONS OF A 5-METHYL-6- REMARK 900 N- METHYLANILINO PYRIDOPYRIMIDINE ANTIFOLATECOMPLEX WITH HUMAN REMARK 900 DIHYDROFOLATE REDUCTASE REMARK 900 RELATED ID: 1DLS RELATED DB: PDB REMARK 900 DIHYDROFOLATE REDUCTASE (DHFR) MUTANT WITH LEU 22 REPLACED BY TYR REMARK 900 (L22Y) COMPLEXED WITH NADPH AND METHOTREXATE REMARK 900 RELATED ID: 1DLR RELATED DB: PDB REMARK 900 DIHYDROFOLATE REDUCTASE (DHFR) MUTANT WITH LEU 22 REPLACED BY PHE REMARK 900 (L22F) COMPLEXED WITH NADPH AND PIRITREXIM (PTX) REMARK 900 RELATED ID: 1U72 RELATED DB: PDB REMARK 900 UNDERSTANDING THE ROLE OF LEU22 VARIANTS IN METHOTREXATERESISTANCE: REMARK 900 COMPARISON OF WILD- TYPE AND LEU22ARG VARIANTMOUSE AND HUMAN REMARK 900 DIHYDRFOLATE REDUCTASE TERNARY CRYSTALCOMPLEXES WITH METHOTREXATE REMARK 900 AND NADPH REMARK 900 RELATED ID: 1OHK RELATED DB: PDB REMARK 900 HUMAN DIHYDROFOLATE REDUCTASE, ORTHORHOMBIC (P21 21 21) CRYSTAL FORM REMARK 900 RELATED ID: 1YHO RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF HUMAN DIHYDROFOLATE REDUCTASECOMPLEXED WITH REMARK 900 TRIMETHOPRIM AND NADPH , 25 STRUCTURES REMARK 900 RELATED ID: 2C2T RELATED DB: PDB REMARK 900 HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 2,4-DIAMINO- REMARK 900 5-((7,8- DICARBAUNDECABORAN-7-YL)METHYL)-6- METHYLPYRIMIDINE, A REMARK 900 NOVEL BORON CONTANING, NONCLASSICAL ANTIFOLATE REMARK 900 RELATED ID: 1OHJ RELATED DB: PDB REMARK 900 HUMAN DIHYDROFOLATE REDUCTASE, MONOCLINIC (P21 ) CRYSTAL FORM REMARK 900 RELATED ID: 1PD9 RELATED DB: PDB REMARK 900 ANALYSIS OF THREE CRYSTAL STRUCTURE DETERMINATIONS OF A 5-METHYL-6- REMARK 900 N- METHYLANILINO PYRIDOPYRIMIDINE ANTIFOLATECOMPLEX WITH HUMAN REMARK 900 DIHYDROFOLATE REDUCTASE REMARK 900 RELATED ID: 1KMV RELATED DB: PDB REMARK 900 HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND (Z)-6-(2-[2, REMARK 900 5-DIMETHOXYPHENYL] ETHEN-1-YL)-2,4-DIAMINO-5-METHYLPYRIDO[2 ,3-D] REMARK 900 PYRIMIDINE (SRI-9662), A LIPOPHILICANTIFOLATE REMARK 900 RELATED ID: 1HFR RELATED DB: PDB REMARK 900 COMPARISON OF TERNARY CRYSTAL COMPLEXES OF HUMAN DIHYDROFOLATE REMARK 900 REDUCTASE WITH NADPH AND A CLASSICAL ANTITUMOR FUROPYRIMDINE REMARK 900 RELATED ID: 1MVT RELATED DB: PDB REMARK 900 ANALYSIS OF TWO POLYMORPHIC FORMS OF A PYRIDO[2,3-D]PYRIMIDINE N9- REMARK 900 C10 REVERSE- BRIDGE ANTIFOLATE BINARYCOMPLEX WITH HUMAN REMARK 900 DIHYDROFOLATE REDUCTASE REMARK 900 RELATED ID: 1U71 RELATED DB: PDB REMARK 900 UNDERSTANDING THE ROLE OF LEU22 VARIANTS IN METHOTREXATERESISTANCE: REMARK 900 COMPARISON OF WILD- TYPE AND LEU22ARG VARIANTMOUSE AND HUMAN REMARK 900 DIHYDROFOLATE REDUCTASE TERNARY CRYSTALCOMPLEXES WITH METHOTREXATE REMARK 900 AND NADPH REMARK 900 RELATED ID: 1KMS RELATED DB: PDB REMARK 900 HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6-([5- REMARK 900 QUINOLYLAMINO]METHYL)-2,4 -DIAMINO-5-METHYLPYRIDO[2,3-D]PYRIMIDINE REMARK 900 ( SRI-9439), A LIPOPHILIC ANTIFOLATE REMARK 900 RELATED ID: 1PDB RELATED DB: PDB REMARK 900 ANALYSIS OF THREE CRYSTAL STRUCTURE DETERMINATIONS OF A 5-METHYL-6- REMARK 900 N- METHYLANILINO PYRIDOPYRIMIDINE ANTIFOLATECOMPLEX WITH HUMAN REMARK 900 DIHYDROFOLATE REDUCTASE REMARK 900 RELATED ID: 1HFQ RELATED DB: PDB REMARK 900 COMPARISON OF TERNARY CRYSTAL COMPLEXES OF HUMAN DIHYDROFOLATE REMARK 900 REDUCTASE WITH NADPH AND A CLASSICAL ANTITUMOR FUROPYRIMDINE REMARK 900 RELATED ID: 1S3U RELATED DB: PDB REMARK 900 STRUCTURE DETERMINATION OF TETRAHYDROQUINAZOLINEANTIFOLATES IN REMARK 900 COMPLEX WITH HUMAN AND PNEUMOCYSTIS CARINIIDIHYDROFOLATE REDUCTASE: REMARK 900 CORRELATIONS OF ENZYMESELECTIVITY AND STEREOCHEMISTRY REMARK 900 RELATED ID: 1DRF RELATED DB: PDB REMARK 900 DIHYDROFOLATE REDUCTASE COMPLEX WITH FOLATE REMARK 900 RELATED ID: 1MVS RELATED DB: PDB REMARK 900 ANALYSIS OF TWO POLYMORPHIC FORMS OF A PYRIDO[2,3-D]PYRIMIDINE N9- REMARK 900 C10 REVERSE- BRIDGE ANTIFOLATE BINARYCOMPLEX WITH HUMAN REMARK 900 DIHYDROFOLATE REDUCTASE REMARK 900 RELATED ID: 1HFP RELATED DB: PDB REMARK 900 COMPARISON OF TERNARY CRYSTAL COMPLEXES OF HUMAN DIHYDROFOLATE REMARK 900 REDUCTASE WITH NADPH AND A CLASSICAL ANTITUMOR FUROPYRIMDINE REMARK 900 RELATED ID: 1BOZ RELATED DB: PDB REMARK 900 STRUCTURE-BASED DESIGN AND SYNTHESIS OF LIPOPHILIC 2,4- DIAMINO-6- REMARK 900 SUBSTITUTED QUINAZOLINES AND THEIR EVALUATION AS INHIBITORS OF REMARK 900 DIHYDROFOLATE REDUCTASE AND POTENTIAL ANTITUMOR AGENTS DBREF 2W3A A 0 186 UNP P00374 DYR_HUMAN 1 187 DBREF 2W3A B 0 186 UNP P00374 DYR_HUMAN 1 187 SEQRES 1 A 187 MET VAL GLY SER LEU ASN CYS ILE VAL ALA VAL SER GLN SEQRES 2 A 187 ASN MET GLY ILE GLY LYS ASN GLY ASP LEU PRO TRP PRO SEQRES 3 A 187 PRO LEU ARG ASN GLU PHE ARG TYR PHE GLN ARG MET THR SEQRES 4 A 187 THR THR SER SER VAL GLU GLY LYS GLN ASN LEU VAL ILE SEQRES 5 A 187 MET GLY LYS LYS THR TRP PHE SER ILE PRO GLU LYS ASN SEQRES 6 A 187 ARG PRO LEU LYS GLY ARG ILE ASN LEU VAL LEU SER ARG SEQRES 7 A 187 GLU LEU LYS GLU PRO PRO GLN GLY ALA HIS PHE LEU SER SEQRES 8 A 187 ARG SER LEU ASP ASP ALA LEU LYS LEU THR GLU GLN PRO SEQRES 9 A 187 GLU LEU ALA ASN LYS VAL ASP MET VAL TRP ILE VAL GLY SEQRES 10 A 187 GLY SER SER VAL TYR LYS GLU ALA MET ASN HIS PRO GLY SEQRES 11 A 187 HIS LEU LYS LEU PHE VAL THR ARG ILE MET GLN ASP PHE SEQRES 12 A 187 GLU SER ASP THR PHE PHE PRO GLU ILE ASP LEU GLU LYS SEQRES 13 A 187 TYR LYS LEU LEU PRO GLU TYR PRO GLY VAL LEU SER ASP SEQRES 14 A 187 VAL GLN GLU GLU LYS GLY ILE LYS TYR LYS PHE GLU VAL SEQRES 15 A 187 TYR GLU LYS ASN ASP SEQRES 1 B 187 MET VAL GLY SER LEU ASN CYS ILE VAL ALA VAL SER GLN SEQRES 2 B 187 ASN MET GLY ILE GLY LYS ASN GLY ASP LEU PRO TRP PRO SEQRES 3 B 187 PRO LEU ARG ASN GLU PHE ARG TYR PHE GLN ARG MET THR SEQRES 4 B 187 THR THR SER SER VAL GLU GLY LYS GLN ASN LEU VAL ILE SEQRES 5 B 187 MET GLY LYS LYS THR TRP PHE SER ILE PRO GLU LYS ASN SEQRES 6 B 187 ARG PRO LEU LYS GLY ARG ILE ASN LEU VAL LEU SER ARG SEQRES 7 B 187 GLU LEU LYS GLU PRO PRO GLN GLY ALA HIS PHE LEU SER SEQRES 8 B 187 ARG SER LEU ASP ASP ALA LEU LYS LEU THR GLU GLN PRO SEQRES 9 B 187 GLU LEU ALA ASN LYS VAL ASP MET VAL TRP ILE VAL GLY SEQRES 10 B 187 GLY SER SER VAL TYR LYS GLU ALA MET ASN HIS PRO GLY SEQRES 11 B 187 HIS LEU LYS LEU PHE VAL THR ARG ILE MET GLN ASP PHE SEQRES 12 B 187 GLU SER ASP THR PHE PHE PRO GLU ILE ASP LEU GLU LYS SEQRES 13 B 187 TYR LYS LEU LEU PRO GLU TYR PRO GLY VAL LEU SER ASP SEQRES 14 B 187 VAL GLN GLU GLU LYS GLY ILE LYS TYR LYS PHE GLU VAL SEQRES 15 B 187 TYR GLU LYS ASN ASP HET GOL A1187 6 HET NDP A1188 48 HET SO4 A1189 5 HET TOP A1190 21 HET GOL B1187 6 HET NDP B1188 48 HET TOP B1189 21 HETNAM GOL GLYCEROL HETNAM NDP NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE HETNAM 2 NDP PHOSPHATE HETNAM SO4 SULFATE ION HETNAM TOP TRIMETHOPRIM HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 GOL 2(C3 H8 O3) FORMUL 4 NDP 2(C21 H30 N7 O17 P3) FORMUL 5 SO4 O4 S 2- FORMUL 6 TOP 2(C14 H18 N4 O3) FORMUL 10 HOH *408(H2 O) HELIX 1 1 LEU A 27 THR A 40 1 14 HELIX 2 2 LYS A 54 SER A 59 1 6 HELIX 3 3 PRO A 61 ARG A 65 5 5 HELIX 4 4 SER A 92 THR A 100 1 9 HELIX 5 5 GLN A 102 ASN A 107 1 6 HELIX 6 6 GLY A 117 ASN A 126 1 10 HELIX 7 7 LEU B 27 THR B 40 1 14 HELIX 8 8 LYS B 54 SER B 59 1 6 HELIX 9 9 PRO B 61 ARG B 65 5 5 HELIX 10 10 SER B 92 THR B 100 1 9 HELIX 11 11 GLY B 117 ASN B 126 1 10 SHEET 1 AA 8 PHE A 88 SER A 90 0 SHEET 2 AA 8 ILE A 71 LEU A 75 1 O VAL A 74 N SER A 90 SHEET 3 AA 8 GLN A 47 GLY A 53 1 O ASN A 48 N ILE A 71 SHEET 4 AA 8 VAL A 109 ILE A 114 1 N ASP A 110 O GLN A 47 SHEET 5 AA 8 SER A 3 VAL A 10 1 O ASN A 5 N ILE A 114 SHEET 6 AA 8 HIS A 130 ILE A 138 1 O HIS A 130 N LEU A 4 SHEET 7 AA 8 ILE A 175 LYS A 184 -1 O LYS A 178 N ARG A 137 SHEET 8 AA 8 LYS A 157 LEU A 158 -1 O LYS A 157 N GLU A 183 SHEET 1 AB 8 PHE A 88 SER A 90 0 SHEET 2 AB 8 ILE A 71 LEU A 75 1 O VAL A 74 N SER A 90 SHEET 3 AB 8 GLN A 47 GLY A 53 1 O ASN A 48 N ILE A 71 SHEET 4 AB 8 VAL A 109 ILE A 114 1 N ASP A 110 O GLN A 47 SHEET 5 AB 8 SER A 3 VAL A 10 1 O ASN A 5 N ILE A 114 SHEET 6 AB 8 HIS A 130 ILE A 138 1 O HIS A 130 N LEU A 4 SHEET 7 AB 8 ILE A 175 LYS A 184 -1 O LYS A 178 N ARG A 137 SHEET 8 AB 8 GLN A 170 GLU A 172 -1 O GLN A 170 N TYR A 177 SHEET 1 AC 2 GLY A 15 GLY A 17 0 SHEET 2 AC 2 THR A 146 PHE A 147 -1 O THR A 146 N ILE A 16 SHEET 1 BA 8 PHE B 88 SER B 90 0 SHEET 2 BA 8 ILE B 71 LEU B 75 1 O VAL B 74 N SER B 90 SHEET 3 BA 8 GLN B 47 GLY B 53 1 O ASN B 48 N ILE B 71 SHEET 4 BA 8 VAL B 109 ILE B 114 1 N ASP B 110 O GLN B 47 SHEET 5 BA 8 SER B 3 SER B 11 1 O ASN B 5 N ILE B 114 SHEET 6 BA 8 HIS B 130 ILE B 138 1 O HIS B 130 N LEU B 4 SHEET 7 BA 8 ILE B 175 LYS B 184 -1 O LYS B 178 N ARG B 137 SHEET 8 BA 8 LYS B 157 LEU B 158 -1 O LYS B 157 N GLU B 183 SHEET 1 BB 8 PHE B 88 SER B 90 0 SHEET 2 BB 8 ILE B 71 LEU B 75 1 O VAL B 74 N SER B 90 SHEET 3 BB 8 GLN B 47 GLY B 53 1 O ASN B 48 N ILE B 71 SHEET 4 BB 8 VAL B 109 ILE B 114 1 N ASP B 110 O GLN B 47 SHEET 5 BB 8 SER B 3 SER B 11 1 O ASN B 5 N ILE B 114 SHEET 6 BB 8 HIS B 130 ILE B 138 1 O HIS B 130 N LEU B 4 SHEET 7 BB 8 ILE B 175 LYS B 184 -1 O LYS B 178 N ARG B 137 SHEET 8 BB 8 GLN B 170 GLU B 172 -1 O GLN B 170 N TYR B 177 SHEET 1 BC 2 GLY B 15 GLY B 17 0 SHEET 2 BC 2 THR B 146 PHE B 147 -1 O THR B 146 N ILE B 16 CISPEP 1 ARG A 65 PRO A 66 0 -5.87 CISPEP 2 GLY A 116 GLY A 117 0 5.72 CISPEP 3 ARG B 65 PRO B 66 0 -7.05 CISPEP 4 GLY B 116 GLY B 117 0 5.13 SITE 1 AC1 6 ARG A 36 GLY A 164 LEU A 166 HOH A2153 SITE 2 AC1 6 HOH A2178 HOH A2179 SITE 1 AC2 29 VAL A 8 ALA A 9 ILE A 16 GLY A 17 SITE 2 AC2 29 GLY A 20 ASP A 21 LEU A 22 GLY A 53 SITE 3 AC2 29 LYS A 54 LYS A 55 THR A 56 LEU A 75 SITE 4 AC2 29 SER A 76 ARG A 77 ARG A 91 VAL A 115 SITE 5 AC2 29 GLY A 117 SER A 118 VAL A 120 TYR A 121 SITE 6 AC2 29 GLU A 123 THR A 146 TOP A1190 HOH A2079 SITE 7 AC2 29 HOH A2180 HOH A2181 HOH A2182 HOH A2183 SITE 8 AC2 29 HOH A2184 SITE 1 AC3 4 ARG A 28 LYS A 173 HOH A2185 ASN B 185 SITE 1 AC4 11 ILE A 7 VAL A 8 ALA A 9 GLU A 30 SITE 2 AC4 11 PHE A 31 PHE A 34 THR A 56 ILE A 60 SITE 3 AC4 11 TYR A 121 THR A 136 NDP A1188 SITE 1 AC5 4 ASP B 168 VAL B 169 HOH B2194 HOH B2219 SITE 1 AC6 29 VAL B 8 ALA B 9 ILE B 16 GLY B 17 SITE 2 AC6 29 GLY B 20 ASP B 21 LEU B 22 GLY B 53 SITE 3 AC6 29 LYS B 54 LYS B 55 THR B 56 LEU B 75 SITE 4 AC6 29 SER B 76 ARG B 77 GLU B 78 ARG B 91 SITE 5 AC6 29 VAL B 115 GLY B 117 SER B 118 SER B 119 SITE 6 AC6 29 VAL B 120 TYR B 121 GLU B 123 THR B 146 SITE 7 AC6 29 TOP B1189 HOH B2134 HOH B2221 HOH B2222 SITE 8 AC6 29 HOH B2223 SITE 1 AC7 11 ILE B 7 VAL B 8 ALA B 9 GLU B 30 SITE 2 AC7 11 PHE B 31 PHE B 34 THR B 56 LEU B 67 SITE 3 AC7 11 TYR B 121 THR B 136 NDP B1188 CRYST1 88.468 94.014 96.576 90.00 90.00 90.00 C 2 2 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011304 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010637 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010355 0.00000 MTRIX1 1 -0.061704 0.997265 -0.040674 -2.14062 1 MTRIX2 1 -0.996466 -0.063879 -0.054546 47.45948 1 MTRIX3 1 -0.056995 0.037164 0.997682 23.25239 1